Duloxetine hydrochloride
CAS No. 136434-34-9
Duloxetine hydrochloride ( LY248686 )
产品货号. M11501 CAS No. 136434-34-9
盐酸度洛西汀是一种选择性血清素和去甲肾上腺素再摄取抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥467 | 有现货 |
|
| 50MG | ¥686 | 有现货 |
|
| 100MG | ¥886 | 有现货 |
|
| 200MG | ¥1107 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥390 | 有现货 |
|
生物学信息
-
产品名称Duloxetine hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述盐酸度洛西汀是一种选择性血清素和去甲肾上腺素再摄取抑制剂。
-
产品描述Duloxetine hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor .(In Vitro):Duloxetine ((S)-Duloxetine hydrochloride) (sold under the brand names Cymbalta, Ariclaim, Xeristar, Yentreve, Duzela, Dulane) is a serotonin-norepinephrine reuptake inhibitor(SNRI) manufactured and marketed by Eli Lilly. It is prescribed for major depressive disorder and generalized anxiety disorder (GAD). Duloxetine also has approval for use in osteoarthiritis and musculoskeletal pain. Duloxetine failed the US approval for stress urinary incontinence amidst concerns over liver toxicity and suicidal events; however, it was approved for this indication in Europe, where it is recommended as an add-on medication in stress urinary incontinence instead of surgery. It can also relieve the symptoms of painful peripheral neuropathy, particularly diabetic neuropathy, and it is used to control the symptoms of fibromyalgia. The main uses of duloxetine are in major depressive disorder, general anxiety disorder, stress urinary incontinence, painful peripheral neuropathy,fibromyalgia, and chronic musculoskeletal pain associated with osteoarthritis and chronic lower back pain. It is being studied for various other indications.
-
体外实验Duloxetine ((S)-Duloxetine hydrochloride) (sold under the brand names Cymbalta, Ariclaim, Xeristar, Yentreve, Duzela, Dulane) is a serotonin-norepinephrine reuptake inhibitor(SNRI) manufactured and marketed by Eli Lilly. It is prescribed for major depressive disorder and generalized anxiety disorder (GAD). Duloxetine also has approval for use in osteoarthiritis and musculoskeletal pain. Duloxetine failed the US approval for stress urinary incontinence amidst concerns over liver toxicity and suicidal events; however, it was approved for this indication in Europe, where it is recommended as an add-on medication in stress urinary incontinence instead of surgery. It can also relieve the symptoms of painful peripheral neuropathy, particularly diabetic neuropathy, and it is used to control the symptoms of fibromyalgia. The main uses of duloxetine are in major depressive disorder, general anxiety disorder, stress urinary incontinence, painful peripheral neuropathy,fibromyalgia, and chronic musculoskeletal pain associated with osteoarthritis and chronic lower back pain. It is being studied for various other indications.
-
体内实验——
-
同义词LY248686
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体Sert (Sodium-dependent)| DA transporter| Noradrenaline transporter (Sodium-dependent)
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number136434-34-9
-
分子量333.88
-
分子式C18H20ClNOS
-
纯度>98% (HPLC)
-
溶解度DMSO: 67 mg/mL (200.67 mM)
-
SMILESCNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
-
化学全称(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Chen F, et al. Eur Neuropsychopharmacol. 2005 Mar; 15(2):193-8.
产品手册
关联产品
-
Dimebolin
Dimebolin 是一种 5-HT6 拮抗剂。
-
Metadoxine
Metadoxine 可通过阻断蛋白激酶 A- cAMP 反应原件结合蛋白 (PKA-CREB) 通路来阻断脂肪细胞的分化。
-
Fluoxetine
Fluoxetine (LY-110140 free base) 是选择性 5-羟色胺再吸收抑制剂 (SSRI)。
021-51111890
购物车()
sales@molnova.cn

